InsidersTradesSigma
Track the VERACYTE INC COM share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €3.5bn. The latest transaction was reported on 4 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: REBECCA CHAMBERS. All data is accessible without an account.
Analysts rate VERACYTE INC COM Buy (bullish), based on 11 analysts. Average price target: US$57.82.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Veracyte Inc 是一家分子诊断公司，提供测试以协助医疗保健领域的临床决策。该公司在纳斯达克上市，股票代码为 VCYT。